Preventing Infections in the NICU

This information is useful for children
Why Yale Medicine?
  • We keep a detailed database of infections so we're able to use antibiotics in a targeted way.
  • We identify the causes of infections, and take steps to prevent them.
  • Our approach has resulted in a reduction in bloodstream infections in the NICU by approximately 80 percent.

Antibiotic resistance is on the rise in the United States, and, with it, the increased risk of serious infections in hospitals. Unfortunately, infections and antimicrobial resistance pose a profound threat to some of the hospital’s most vulnerable inpatients—newborns. Many patients in the neonatal intensive care unit (NICU) are premature and their immune systems are weak, so we take extra care to protect them.

We keep a detailed database of types of infections, tracking the latest trends and the newest strains. As a result, we're able to use antibiotics in a targeted way.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.